Covered recipient · General Payments record
HUSEIN BADANI
General Payments · PY2024
$663.65
- Reported across 7 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $663.65 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $124.99 | 1 |
| SK Life Science, Inc. | $124.99 | 1 |
| GlaxoSmithKline, LLC. | $122.31 | 1 |
| Acerta Pharma LLC | $119.96 | 1 |
| Astellas Pharma US Inc | $91.67 | 1 |
| SECURA BIO, INC. | $54.07 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $25.66 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $663.65 | 7 |
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $91.67 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287191 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110513616 | CMS |
| GlaxoSmithKline, LLC. | $122.31 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116562442 | CMS |
| Merck Sharp & Dohme LLC | $124.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141568100 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $25.66 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139161152 | CMS |
| Secura Bio, Inc. | $54.07 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133336279 | CMS |
| SK Life Science, Inc. | $124.99 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137390 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.